|
1
|
Luo H, Tu G, Liu Z and Liu M:
Cancer-associated fibroblasts: A multifaceted driver of breast
cancer progression. Cancer Lett. 361:155–163. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Han Y, Zhang Y, Jia T and Sun Y: Molecular
mechanism underlying the tumor-promoting functions of
carcinoma-associated fibroblasts. Tumour Biol. 36:1385–1394. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Catteau X, Simon P and Noël JC:
Myofibroblastic stromal reaction and lymph node status in invasive
breast carcinoma: Possible role of the TGF-β1/TGF-βR1 pathway. BMC
Cancer. 14:4992014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Catteau X, Simon P and Noël JC:
Myofibroblastic reaction is a common event in metastatic disease of
breast carcinoma: A descriptive study. Diagn Pathol. 9:1962014.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kohlhapp FJ, Mitra AK, Lengyel E and Peter
ME: MicroRNAs as mediators and communicators between cancer cells
and the tumor microenvironment. Oncogene April. 13:2015.(Epub ahead
of print).
|
|
6
|
Hassona Y, Cirillo N, Heesom K, Parkinson
EK and Prime SS: Senescent cancer-associated fibroblasts secrete
active MMP-2 that promotes keratinocyte dis-cohesion and invasion.
Br J Cancer. 111:1230–1237. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jezierska A and Motyl T: Matrix
metalloproteinase-2 involvement in breast cancer progression: A
mini-review. Med Sci Monit. 15:RA32–RA40. 2009.PubMed/NCBI
|
|
8
|
Lakhani SR, Ellis IO, Schnitt SJ, Tan PH
and van de Vijver MJ: Invasive breast carcinoma: Introduction and
general features. WHO Classification of Tumours. 4:(4th). (Lyon).
IARC Press. 19–22. 2012.
|
|
9
|
Hammond ME, Hayes DF, Dowsett M, Allred
DC, Hagerty KL, Badve S, Fitzgibbons PL, Francis G, Goldstein NS,
Hayes M, et al: American Society of Clinical Oncology/College of
American Pathologists guideline recommendations for
immunohistochemical testing of estrogen and progesterone receptors
in breast cancer. J Clin Oncol. 28:2784–2795. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wolff AC, Hammond ME, Hicks DG, Dowsett M,
McShane LM, Allison KH, Allred DC, Bartlett JM, Bilous M,
Fitzgibbons P, et al: Recommendations for human epidermal growth
factor receptor 2 testing in breast cancer: American Society of
Clinical Oncology/College of American Pathologists clinical
practice guideline update. J Clin Oncol. 31:3997–4013. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Preat F, Simon P and Noel JC: Differences
in breast carcinoma immunohistochemical subtypes between immigrant
Arab and European women. Diagn Pathol. 9:262014. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sihto H, Lundin J, Lundin M, Lehtimäki T,
Ristimäki A, Holli K, Sailas L, Kataja V, Turpeenniemi-Hujanen T,
Isola J, et al: Breast cancer biological subtypes and protein
expression predict for the preferential distant metastasis sites: A
nationwide cohort study. Breast Cancer Res. 13:R872011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kennecke H, Yerushalmi R, Woods R, Cheang
MC, Voduc D, Speers CH, Nielsen TO and Gelmon K: Metastatic
behavior of breast cancer subtypes. J Clin Oncol. 28:3271–3277.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
De Wever O, Demetter P, Mareel M and
Bracke M: Stromal myofibroblasts are drivers of invasive cancer
growth. Int J Cancer. 123:2229–2238. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Finak G, Bertos N, Pepin F, Sadekova S,
Souleimanova M, Zhao H, Chen H, Omeroglu G, Hallett M and Park M:
Stromal gene expression predicts clinical outcome in breast cancer.
Nat Med. 14:518–527. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Farmer P, Bonnefoi H, Anderle P, Cameron
D, Wirapati P, Becette V, André S, Piccart M, Campone M, Brain E,
et al: A stroma-related gene signature predicts resistance to
neoadjuvant chemotherapy in breast cancer. Nat Med. 15:68–74. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Gupta GP and Massagué J: Cancer
metastasis: Building a framework. Cell. 127:679–695. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Duffy MJ, Maguire TM, Hill A, McDermott E
and O'Higgins N: Metalloproteinases: Role in breast carcinogenesis,
invasion and metastasis. Breast Cancer Res. 2:252–257. 2000.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Jones JL, Glynn P and Walker RA:
Expression of MMP-2 and MMP-9, their inhibitors and the activator
MT1-MMP in primary breast carcinomas. J Pathol. 189:161–168. 1999.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Thompson EW, Yu M, Bueno J, Jin L, Maiti
SN, Palao-Marco FL, Pulyaeva H, Tamborlane JW, Tirgari R and Wapnir
I: Collagen induced MMP-2 activation in human breast cancer. Breast
Cancer Res Treat. 31:357–370. 1994. View Article : Google Scholar : PubMed/NCBI
|
